Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

RPR and Stanford enter research agreement for drug discovery and gene therapy

May 23, 1997

DepoMed seeks alliances for drug delivery systems

May 21, 1997

HemaSure stops development of SteriPath

May 20, 1997

LXR and Oxford Asymmetry enter drug discovery collaboration

May 14, 1997

Sugen researchers discover co-crystal of FGF TK

May 14, 1997

Avigen's gene therapy approach shows promise in preclinical studies

May 14, 1997

Cubist and Novalon collaborative research agreement

May 13, 1997

Titan receives U.S. patent for drug delivery to the CNS

May 13, 1997

Sonus and Valois collaborate on development of aerosol drug delivery system

May 12, 1997

Glaxo obtains license to technology and porphyrin compound for dermatological diseases

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...